دورية أكاديمية
Changes in health-related quality of life after ultrasound-guided foam sclerotherapy for great and small saphenous varicose veins.
| العنوان: | Changes in health-related quality of life after ultrasound-guided foam sclerotherapy for great and small saphenous varicose veins. |
|---|---|
| المؤلفون: | Darvall KA; Birmingham University Department of Vascular Surgery, Heart of England NHS Trust, Birmingham, United Kingdom. katydarvall@btinternet.com, Sam RC, Bate GR, Silverman SH, Adam DJ, Bradbury AW |
| المصدر: | Journal of vascular surgery [J Vasc Surg] 2010 Apr; Vol. 51 (4), pp. 913-20. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: United States NLM ID: 8407742 Publication Model: Print Cited Medium: Internet ISSN: 1097-6809 (Electronic) Linking ISSN: 07415214 NLM ISO Abbreviation: J Vasc Surg Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2008-> : New York, NY : Elsevier Original Publication: St. Louis, Mo. : Mosby, [c1984- |
| مواضيع طبية MeSH: | Quality of Life* , Sclerotherapy* , Ultrasonography, Interventional*, Saphenous Vein/*diagnostic imaging , Sclerosing Solutions/*therapeutic use , Varicose Veins/*therapy, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Stockings, Compression ; Surveys and Questionnaires ; Time Factors ; Treatment Outcome ; Varicose Veins/diagnostic imaging ; Varicose Veins/psychology ; Young Adult |
| مستخلص: | Background: Health-related quality of life (HRQOL) improves after superficial venous surgery for varicose veins, but the effect of ultrasound-guided foam sclerotherapy on HRQOL is unknown. The aim of this study was to determine changes in HRQOL after ultrasound-guided foam sclerotherapy for varicose veins. Methods: Consecutive patients undergoing ultrasound-guided foam sclerotherapy for varicose veins were sent the Short Form 12 (SF-12) questionnaire, a generic measure of HRQOL, and the Aberdeen Varicose Vein Symptom Score (AVSS) questionnaire, a disease-specific measure of HRQOL, 1 week before treatment and 1, 6, and 12 months after treatment. Results: The study enrolled 296 patients (34% male; 395 treated legs) with a median age of 57 years (range, 22-89 years). Of these, 24% had had previous superficial venous surgery, and 66% were CEAP C(2-3) (uncomplicated varicose veins). Questionnaire completion rates were 82%, 73%, and 69% at 1, 6, and 12 months after treatment. The median Physical Component Summary score of the SF-12 (higher score indicates better HRQOL) improved from 47.6 pretreatment to 49.4 at 1 month (P < .008, Wilcoxon signed rank test), to 51.9 at 6 months (P < .0005), and to 52.9 at 12 months (P < .0005). The median AVSS (lower score indicates better HRQOL) improved from 19.0 pretreatment to 16.5 at 1 month (P < .0005), to 8.7 at 6 months (P < .0005), and to 8.6 at 12 months (P < .0005). Conclusions: Ultrasound-guided foam sclerotherapy for great and small saphenous varicose veins leads to significant improvements in generic and disease-specific HRQOL for at least 12 months after treatment. |
| المشرفين على المادة: | 0 (Sclerosing Solutions) |
| تواريخ الأحداث: | Date Created: 20100330 Date Completed: 20100415 Latest Revision: 20161125 |
| رمز التحديث: | 20221213 |
| DOI: | 10.1016/j.jvs.2009.11.045 |
| PMID: | 20347688 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1097-6809 |
|---|---|
| DOI: | 10.1016/j.jvs.2009.11.045 |